GSK to open clinical data vaults to scientists via website

GlaxoSmithKline ($GSK) committed to provide researchers with unmatched access to patient-level data from its clinical trials–including studies that failed. The move is among several steps the London-based drug giant announced today to promote open innovation and collaboration with external groups. Yet commentators are skeptical about whether fellow drugmakers will be as bold in opening their data vaults to outsiders.

By Ryan McBride

Full Story: http://www.fiercebiotechit.com/story/gsk-open-clinical-data-vaults-scientists-website/2012-10-11